DEXDOR Trademark

Trademark Overview

On Tuesday, April 13, 2021, a trademark application was filed for DEXDOR with the United States Patent and Trademark Office. The USPTO has given the DEXDOR trademark a serial number of 79311029. The federal status of this trademark filing is REGISTERED as of Tuesday, October 18, 2022. This trademark is owned by Orion Corporation. The DEXDOR trademark is filed in the Pharmaceutical Products category with the following description:

Anesthetic and sedative medicines for intravenous administration in an intensive care setting
dexdor

General Information

Serial Number79311029
Word MarkDEXDOR
Filing DateTuesday, April 13, 2021
Status700 - REGISTERED
Status DateTuesday, October 18, 2022
Registration Number6874489
Registration DateTuesday, October 18, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements

Goods and ServicesAnesthetic and sedative medicines for intravenous administration in an intensive care setting

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOrion Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFI
Party NameOrion Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFI
Party NameOrion Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFI

Trademark Events

Event DateEvent Description
Monday, February 27, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 3, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 3, 2023FINAL DISPOSITION PROCESSED
Wednesday, January 18, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 18, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 18, 2022REGISTERED-PRINCIPAL REGISTER
Monday, August 8, 2022NOTIFICATION PROCESSED BY IB
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 13, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 13, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, January 22, 2022REFUSAL PROCESSED BY IB
Monday, January 3, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, January 3, 2022REFUSAL PROCESSED BY MPU
Sunday, December 12, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, December 11, 2021NON-FINAL ACTION WRITTEN
Saturday, December 4, 2021ASSIGNED TO EXAMINER
Friday, May 21, 2021APPLICATION FILING RECEIPT MAILED
Monday, May 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 14, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

dexdor intensive care setting administration intravenous sedative medicines anesthetic